Company Profiles

driven by the PitchBook Platform

Tocagen

Description

Developer of cancer-selective gene therapies designed to activate a patient's immune system against their own cancer from within. The company's gene therapy technology deliver therapeutic genes into the DNA of cancer cells and activate a patient's immune system to fight against their cancer from within, enabling cancer patients to safely and effectively control the disease.

2007

Founded

PUBLIC

Status

51-200

Employees

IPO

Latest Deal Type

$85M

Latest Deal Amount

$124M

Total Amount Raised

Description

Developer of cancer-selective gene therapies designed to activate a patient's immune system against their own cancer from within. The company's gene therapy technology deliver therapeutic genes into the DNA of cancer cells and activate a patient's immune system to fight against their cancer from within, enabling cancer patients to safely and effectively control the disease.

Website:

www.tocagen.com

Ownership Status

Publicly held

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

3030 Bunker Hill Street Suite 230 San Diego, CA 92109United States +1 (858) 412-8400
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Tocagen's full profile, request a free trial.

Tocagen Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Tocagen Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Tocagen Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Martin DuvallChief Executive Officer & Board Member
Harry Gruber MDCo-Founder, Board Member & President, Research & Development
Mark FolettaChief Financial Officer & Executive Vice President
Ching-I ChenDirector, Process Development and Manufacturing
Douglas Jolly Ph.DExecutive Vice President of Research & Pharmaceutical Development and Co-Founder
Martin Duvall Chief Executive Officer & Board Member
Harry Gruber MD Co-Founder, Board Member & President, Research & Development
Mark Foletta Chief Financial Officer & Executive Vice President
Ching-I Chen Director, Process Development and Manufacturing
Douglas Jolly Ph.D Executive Vice President of Research & Pharmaceutical Development and Co-Founder

Tocagen Board Members (9)

NameRepresentingRoleSinceContact
Info
David Parkinson MDSelfBoard Member000 0000
Dennis Berman JDTocagenCo-Founder, Board Member and Executive Vice President, Corporate Development000 0000
Faheem HasnainTocagenBoard Member000 0000
Franklin BergerSelfBoard Member000 0000
Harry Gruber MDTocagenCo-Founder, Board Member & President, Research & Development000 0000
David Parkinson MD Board Member Self
Dennis Berman JD Co-Founder, Board Member and Executive Vice President, Corporate Development Tocagen
Faheem Hasnain Board Member Tocagen
Franklin Berger Board Member Self
Harry Gruber MD Co-Founder, Board Member & President, Research & Development Tocagen
Request full access to PitchBook